Home / Treatment Library / Jeuveau®
Precision wrinkle treatment. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Your anatomy, expression and goals guide every recommendation—so the result still feels unmistakably like you.
Jeuveau® is prabotulinumtoxinA-xvfs, and it is the only one of the four that exists purely for aesthetics. Its FDA indication is the temporary improvement in the appearance of moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity in adults — and its boxed warning states plainly that it is not approved for spasticity or any condition other than glabellar lines. Where the other three carry long lists of medical indications, Jeuveau® was developed and approved for this one cosmetic use.
Jeuveau® is the narrowest product of the four, and that narrowness is the point rather than a limitation.
Botox® Cosmetic, Dysport® and Xeomin® all share a molecule with therapeutic products carrying indications for conditions like spasticity, cervical dystonia and chronic sialorrhea. Jeuveau® does not. Its label is one cosmetic indication, and its boxed warning says so explicitly.
The indication names the corrugator and procerus muscles — the frown-line complex between the brows. Xeomin® and Botox® Cosmetic carry broader cosmetic labeling across the upper face.
A Jeuveau® unit is not a Botox®, Dysport® or Xeomin® unit. If you are moving to Jeuveau® from another product, the provider builds a new dose from your anatomy and prior response rather than converting a number.
Product selection is a clinical decision made with you at consultation. Nothing here is a recommendation for a specific product, and no toxin can be dosed from a web page.
Adults who want the frown lines between their brows treated, and nothing else on this visit. Jeuveau®’s indication is the glabellar complex — the corrugator and procerus muscles — and its boxed warning states plainly that it is not approved for spasticity or any condition other than glabellar lines. A good candidate understands the result is temporary, that asymmetry is possible, and that a narrow label is a reason for confidence in that area rather than a limitation.
Treatment may be deferred for pregnancy or breastfeeding, active infection at an injection site, known allergy to an ingredient, certain neuromuscular disorders, or symptoms that require medical evaluation. Tell the provider about all medications, supplements, prior toxin products and any swallowing or breathing problems. If your goal is the forehead, the outer eye or the neck, Jeuveau® is not the product for it and your provider will say so.
These are practical planning ranges, not promises. Your consultation determines the exact plan.
Your provider reviews health history, prior toxin use and how the corrugator and procerus muscles pull when you frown. This is the area Jeuveau® is approved for.
Expression patterns are mapped and the skin is cleansed. Small measured injections are placed with a fine needle, dosed from your own muscle strength rather than converted from another product.
You receive aftercare and a follow-up window. Do not judge symmetry before the product has had time to settle, which can take up to two weeks.
Expected effects can include temporary redness, tenderness, bruising, swelling or asymmetry. Every botulinum toxin product carries a boxed warning about distant spread of toxin effect: rare but serious risks include swallowing, speaking or breathing difficulty. Units of one product cannot be compared to or converted into units of another. Treatment cannot be guaranteed and must follow an individualized examination.
Small differences in depth, angle, dose and muscle selection change the outcome. An experienced medical injector can distinguish dynamic lines from volume loss, protect brow and eyelid function, plan around asymmetry and recognize complications early.
Treatment is in-office only. Telehealth can answer general questions, but facial examination, consent and injections occur at an Identity Aesthetics location.
Pricing: From $14 per unit. Final cost depends on the number of units selected after assessment. Always ask about current promotions and volume savings.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Jeuveau®—or an alternative—makes sense.
